MGF (Mechano Growth Factor)
Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that is naturally produced in muscle tissue following mechanical stress or damage. Research indicates it plays a crucial role in muscle repair and growth by activating muscle stem cells (satellite cells). While highly promising in animal models for tissue regeneration and neuroprotection, human clinical trials on administered MGF are currently lacking.
01Dosing reference
02Mechanism of action
Mechanical Stress Response
Following muscle damage or mechanical overload, the IGF-1 gene undergoes alternative splicing to produce MGF (IGF-1Ec).
Satellite Cell Activation
MGF acts locally to stimulate the activation and proliferation of muscle satellite cells (stem cells) rather than promoting immediate differentiation.
Tissue Repair and Hypertrophy
The expanded pool of satellite cells eventually fuses with existing muscle fibers, facilitating repair, regeneration, and muscle growth.
03Human evidence
Endogenous MGF expression increases after exercise
Observational studies in humans show that resistance training upregulates MGF mRNA in skeletal muscle, though this relates to natural production rather than exogenous administration.
Lack of clinical trials for exogenous MGF
There is currently no robust clinical trial data evaluating the safety or efficacy of administered MGF peptides in humans.
04Preclinical evidence
Enhanced muscle regeneration
In rodent models of muscle injury, MGF administration significantly accelerated muscle repair and increased muscle fiber cross-sectional area.
Neuroprotective effects
Animal studies demonstrate that MGF can protect neurons from ischemia-induced damage and promote motor neuron survival in models of neurodegeneration.
05What is known vs. unknown
- MGF is an alternative splice variant of the IGF-1 gene, specifically known as IGF-1Ec in humans.
- It is naturally upregulated in response to mechanical stress, exercise, or tissue damage.
- Its primary mechanism involves stimulating the proliferation of muscle satellite cells.
- MGF has a very short half-life in vivo, leading researchers to develop PEGylated versions (PEG-MGF) to extend its activity.
- Beyond muscle tissue, preclinical research suggests MGF has significant neuroprotective and cardioprotective properties.
- The specific receptor for MGF has not been definitively identified, though it acts independently of the standard IGF-1 receptor.
- There is a lack of human clinical trials evaluating the safety, efficacy, and optimal dosing of exogenous MGF.
- Long-term effects of MGF administration, particularly regarding cellular proliferation and cancer risk, remain unknown.
06Safety & regulatory context
07Compared with IGF-1 LR3
08Glossary
09Knowledge check
10Sources
More in Healing & Recovery
BPC-157
BPC-157 is a synthetic peptide sequence based on a protective compound naturally found in human gastric juice. Research suggests it has significant regenerative properties, promoting the healing of tendons, ligaments, muscles, and the gastrointestinal tract by accelerating angiogenesis and modulating growth factors.
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic version of the naturally occurring peptide Thymosin Beta-4. Research indicates it plays a crucial role in tissue repair, wound healing, and reducing inflammation by upregulating actin, a vital protein for cell structure and movement.
KPV
KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH). Research highlights its potent anti-inflammatory and antimicrobial properties, making it a promising candidate for conditions like inflammatory bowel disease, skin disorders, and wound healing.